GlassScriptPhysician profile
Sheila Samaddar
NPI 1659438463
$6,742.95
in general payments reported to CMS, 2019-2025
14 companies · $362 in 2025
The $362 reported for 2025 was more than what 87% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $1,509 · 2021: $369 · 2022: $322 · 2023: $2,672 · 2024: $646 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,730 · Travel and Lodging: $1,619 · Consulting Fee: $175 · Gift: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,729.99 |
| Travel and Lodging | $1,619.22 |
| Consulting Fee | $175.00 |
| Gift | $155.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,767.50 | 2019-2025 | Itero, Invisalign |
| Zimvie INC. | $2,648.04 | 2022-2024 | |
| Bisco, INC. | $459.98 | 2023 | |
| Zimmer Biomet Holdings, INC. | $186.31 | 2019-2021 | |
| Ortho Organizers, INC. | $161.22 | 2023 | Carriere |
| Nsk America Corporation | $155.56 | 2025 | |
| Southern Implants North America INC | $136.38 | 2023 | |
| Nobel Biocare USA | $75.75 | 2022 | |
| Pulpdent Corporation | $73.07 | 2020 | |
| 3m Company | $26.02 | 2019-2021 | |
| Envista Holdings Corporation | $15.27 | 2024 | Endodontics |
| Dentsply Sirona INC | $13.36 | 2020 | |
| Kerr Corporation | $13.15 | 2022 | |
| Voco America INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Samaddar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.